Vaccination for COVID-19 in Patients with Heart Failure with Reduced Ejection Fraction

I. Schonhofen, Andreya Fernandes, T. Macêdo, B. Silveira, B. Costa, M. Feitosa
{"title":"Vaccination for COVID-19 in Patients with Heart Failure with Reduced Ejection Fraction","authors":"I. Schonhofen, Andreya Fernandes, T. Macêdo, B. Silveira, B. Costa, M. Feitosa","doi":"10.51941/amcr.2022.2103","DOIUrl":null,"url":null,"abstract":"The new Coronavirus disease was first identified from an outbreak in Wuhan, China, in December 2019. Patients with cardiovascular diseases or risk factors, especially those who had been diagnosed with Heart Failure (HF) have been expressing great concern.This population became more vulnerable when contaminated with the Sars cov 2 virus [1]. Questions have been raised about vaccines as they were developed by research centers and pharmacy industry.","PeriodicalId":310782,"journal":{"name":"Archives of Medical and Clinical Research","volume":"7 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2022-04-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Archives of Medical and Clinical Research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.51941/amcr.2022.2103","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

The new Coronavirus disease was first identified from an outbreak in Wuhan, China, in December 2019. Patients with cardiovascular diseases or risk factors, especially those who had been diagnosed with Heart Failure (HF) have been expressing great concern.This population became more vulnerable when contaminated with the Sars cov 2 virus [1]. Questions have been raised about vaccines as they were developed by research centers and pharmacy industry.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
心力衰竭伴射血分数降低患者的COVID-19疫苗接种
这种新型冠状病毒疾病最初是在2019年12月中国武汉的一次疫情中发现的。有心血管疾病或危险因素的患者,特别是那些被诊断为心力衰竭(HF)的患者已经表达了极大的关注。这一人群在感染Sars冠状病毒后变得更加脆弱[1]。在研究中心和制药行业开发疫苗的过程中,人们对疫苗提出了质疑。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Vaccination for COVID-19 in Patients with Heart Failure with Reduced Ejection Fraction Topical Treatment of Cutaneous Leishmaniasis: A Case Treated with A Glucantime-Based Lotion Experienced in Ecuador and A Mini Review Incidence of HIV Cases and Associated Factors in The Northeast Region of Brazil Colocutaneous Fistula in the Untreated Elderly with Quiescent Crohn's Disease Benefits of Buerger-Allen Exercises for Diabetic people: A Mini-Review
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1